University of Washington
Cardiovascular Disease fellowship · Seattle, WA · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is University of Washington's research in cardiovascular disease, which the program shares with other departments and affiliated hospitals.
About University of Washingtoninstitution-wide cardiovascular disease research
Cardiovascular Disease publications from University of Washington and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
264
works per year
11th of 78 cardiovascular disease fellowship programs
-3.5%
2-year growth
63rd of 78 cardiovascular disease fellowship programs
31.2%
in top 10% of field (works before 2025)
15th of 74 cardiovascular disease fellowship programs
52.5%
cited above world average
12th of 74 cardiovascular disease fellowship programs
Works per year · * 2026 so far
Cardiology and Cardiovascular Medicine · 1,305
Cardiovascular Disease research topics at University of Washington
Papers in the window; each links to the list on OpenAlex.
- Cardiac Valve Diseases and Treatments 130
- Atrial Fibrillation Management and Outcomes 125
- Heart Failure Treatment and Management 118
- Cardiomyopathy and Myosin Studies 105
- Blood Pressure and Hypertension Studies 104
- Cardiac electrophysiology and arrhythmias 74
- Cardiovascular Effects of Exercise 71
- Cardiovascular Function and Risk Factors 69
Most cited at University of Washington since 2024
All cardiovascular disease papers there on OpenAlex
- Atrial cardiomyopathy revisited—evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS)Andreas Goette et al. · EP Europace · 2024 · PubMed · cited 341
- Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trialsMikhail Kosiborod et al. · The Lancet · 2024 · PubMed · cited 323
- Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trialJohn Eric Deanfield et al. · The Lancet · 2024 · PubMed · cited 302
- Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial CardiopathyHooman Kamel et al. · JAMA · 2024 · PubMed · cited 223
- Estatística Cardiovascular – Brasil 2023Gláucia Maria Moraes de Oliveira et al. · Arquivos Brasileiros de Cardiologia · 2024 · PubMed · cited 185
- Pericardial DiseasesAllan L. Klein et al. · JACC. Cardiovascular imaging · 2024 · PubMed · cited 181
- 2024 HRS expert consensus statement on arrhythmias in the athlete: Evaluation, treatment, and return to playRachel J. Lampert et al. · Heart Rhythm · 2024 · PubMed · cited 179
- Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm studyTorsten Peter Vahl et al. · The Lancet · 2024 · PubMed · cited 175
- 2025 American Society of Anesthesiologists Practice Advisory for Perioperative Care of Older Adults Scheduled for Inpatient SurgeryFrederick E. Sieber et al. · Anesthesiology · 2024 · PubMed · cited 125
- Cardio-Oncology and Heart Failure: a Scientific Statement From the Heart Failure Society of AmericaMichelle Weisfelner Bloom et al. · Journal of Cardiac Failure · 2024 · PubMed · cited 120